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Background {#Sec2}
==========

Tuberculosis (TB) control remains a major public health challenge in low-income countries with a high incidence of TB, particularly where HIV prevalence is also high \[[@CR1]\]. In these settings, TB accounts for approximately 40% of adult deaths. In almost half of these cases, the disease remains undiagnosed until death \[[@CR2]\]. TB patients are often diagnosed at the later stages of the disease, due to health-seeking behaviour, inappropriate diagnostic investigations requested by health care providers, and limited diagnostic capacities at health care facilities (HCFs) \[[@CR3], [@CR4]\]. Patients experiencing TB symptoms may initially seek relief by using self-prescribed medication or by consulting a health care provider who does not request TB investigations despite repeated visits \[[@CR5]\]. The economic burden of seeking care remains a barrier for TB patients \[[@CR6]\].

Delaying diagnosis and treatment of TB has important consequences for disease control at both the individual as well as the community level. At the individual level, a patient with a delayed diagnosis of TB risks advanced disease states and worse treatment outcomes. At community level, a patient with delayed diagnosis is infectious to close contacts; an untreated smear-positive TB case infects approximately 15 people annually \[[@CR7], [@CR8]\]. Delay in seeking care, therefore, promotes continued TB transmission \[[@CR9]\]. The complex pathway to care, from the onset of symptoms to diagnosis and treatment, may result in delays in seeking care and contribute to patient morbidity and mortality \[[@CR4], [@CR10]\].

Tanzania is among the 30 countries with the highest TB burdens \[[@CR11]\]. TB case detection in Tanzania largely relies on passive case detection when patients present themselves to HCFs, which likely leads to longer diagnostic delays \[[@CR12]\]. The first national TB prevalence survey in Tanzania in 2012 showed that only 30% of people with TB symptoms sought health care and almost half of these did not undergo diagnostic procedures for TB \[[@CR4]\]. To better understand this situation, we studied the extent of diagnostic delay of TB, its associated risk factors and factors contributing to health-seeking behaviour among newly diagnosed smear-positive adult pulmonary TB (PTB) patients in Dar es Salaam, an urban region in Tanzania with a high TB burden.

Methods {#Sec3}
=======

Study setting and study population {#Sec4}
----------------------------------

We collected data from an ongoing prospective cohort of smear-positive adult PTB patients (≥18 years) in Dar es Salaam, Tanzania (TB-DAR). TB-DAR was initiated in November 2013 to study the epidemiology and molecular epidemiology of TB in the densely populated Temeke district in Tanzania's commercial capital, Dar es Salaam. Dar es Salaam, with a population of about 4.4 million and rapid urbanization \[[@CR13]\], accounted for nearly 22% of the 65 732 TB cases notified in 2013 to the National Tuberculosis and Leprosy Programme (NTLP) in Tanzania \[[@CR14], [@CR15]\]. The Temeke district has approximately 1.4 million people and reported 4,373 TB cases in 2014 \[[@CR15]\]. The main sources of income in the district are food crop sales and small businesses \[[@CR16]\].

Eligibility criteria for TB-DAR study participants were as follows: 1) ≥18 years of age at recruitment, 2) sputum microscopy smear-positive TB (quantification grading at least scanty), 3) residency in Wailes I and II sub-districts of Temeke and 4) attends the TB clinic at the Temeke District Hospital or one of its associated TB satellite treatment centers, Tambukareli and Pasada. Patients with confirmed TB were started on standard TB treatment regimen within 1 day of diagnosis, as per the national guidelines \[[@CR17]\]. Diagnostic and treatment services for TB are provided free of charge by the NTLP.

For this analysis, we included newly diagnosed smear-positive adult PTB cases who were enrolled between November 2013 and June 2015. The selection of eligible patients is shown in Fig. [1](#Fig1){ref-type="fig"}. Of the 525 smear-positive PTB patients enrolled in the TB-DAR Study during this time period, we excluded 12 (2.3%) patients for the following reasons: 10 (2%) relapse patients, 1 (0.2%) loss to follow-up and 1 (0.2%) treatment failure (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Flow chart of patient selection

According to the national guidelines \[[@CR17]\], presumptive PTB cases (outpatient or inpatient) are counseled to bring sputum samples to the laboratory; patients with a smear-positive result or smear-negative TB cases with clinical features suggestive of TB (and/or based on additional tests such as chest X-ray) are immediately started on TB treatment.

Data collection and definitions {#Sec5}
-------------------------------

Clinical officers with extensive experience in clinical research interviewed patients using standardized questionnaires \[[@CR18]\]. Officers collected data on socio-demographic and socio-economic characteristics and on health-seeking behaviour at the time of enrolment. In ascertaining signs and symptoms suggestive of TB, we posed specific questions (patient ever having felt sick of any symptom such as coughing, chest pain, fever, weight loss, hemoptysis, night sweats) and patients were asked to recall the duration of symptoms (in weeks) \[[@CR19]\]. Duration of diagnostic delay was calculated based on the longest reported TB-related symptom.

A new adult TB case was defined as a patient aged ≥ 18 years with newly diagnosed smear-positive (at least scanty) pulmonary TB. Sputum microscopy was performed using fluorescent light-emitting diode (LED) microscopy and the quantitative scoring system was based on the number of acid-fast bacilli (AFB) according to the national guidelines \[[@CR17], [@CR20]\]: scanty, 1+, 2+, and 3+. Diagnostic delay was defined as the time from onset of any TB-related symptom (patient ever having felt sick of any symptom such as coughing, chest pain, fever, weight loss, hemoptysis and night sweat) until the time of TB diagnosis \[[@CR3], [@CR19], [@CR21], [@CR22]\]. Health Care Facilities (HCFs) were defined as places that provide health care, including hospitals, health centers and dispensaries. Prior medication was defined as the use of any self-prescribed or prescribed medication prior to TB diagnosis and any medication other than anti-TB, antiretroviral therapy (ART) or co-trimoxazole (for patients co-infected with HIV). Multiple HCF visits were defined as seeking health care from formal health providers more than twice.

Statistical analysis {#Sec6}
--------------------

Descriptive analyses were performed to summarize the data. For the purpose of this study, we categorized diagnostic delay into two categories: 3 weeks or less and more than 3 weeks. We considered 3 weeks as a cutoff for diagnostic delay based on the distribution of the delay in our study population (Additional file [2](#MOESM2){ref-type="media"}: Figure S1) and the range of diagnostic delay reported in a systematic review \[[@CR23]\]. Associations between dependent variables (delay of ≤ 3 and \> 3 weeks) and independent variables (such as age, sex, occupation, household income, household size, TB symptoms, prior use of medication, and number of HCF visits) were analyzed using logistic regression models. Variables were included in the multivariate model if thought to be clinically or socially relevant or had a *P*-value of \< 0.05 following univariate analysis. Result are presented as crude (*OR*) and adjusted odds ratios (a*OR*). All analyses were performed in STATA software version 13.1 (Stata Corporation, Collage Station, Texas, USA).

Geographical analysis {#Sec7}
---------------------

We collected geocodes using Android tablets (Samsung) for all known pharmacies, dispensaries (public/private), and hospitals, identified during extensive fieldwork in the study area. In addition, all study participants' households were geocoded. We generated maps using the open source software QGIS version 2.10.1 \[[@CR24]\]. We then calculated the Euclidean distances in meters as a linear distance matrix between participants' households and the nearest pharmacy. The resulting Euclidean distances were then imported into STATA software for further analyses. To overcome separation in conventional logistic models, we created penalized likelihood models using the firth logit command in STATA and assessed the association between an incremental increase of 500 meters (distance between household and the nearest pharmacy) with binary outcomes (prior use of medication, diagnostic delay and any visit to a HCF) \[[@CR25]\]. Results were presented as unadjusted *OR*s (Fig. [3](#Fig3){ref-type="fig"}).

Results {#Sec8}
=======

Patient characteristics {#Sec9}
-----------------------

We analysed 513 newly diagnosed smear-positive adult PTB patients. The median age was 34 years (interquartile range \[IQR\]: 27--41 years, range 18--79); 353 (69%) were men and 147 (29%) were HIV-positive (Table [1](#Tab1){ref-type="table"}). The proportion of HIV was higher among women compared to men (43%, versus 22%; *P* \< 0.001). Of the 147 HIV-positive patients, 37 (25%) were on ART prior to TB diagnosis and 86 (59%) started ART within 7 weeks of TB diagnosis; ART information was unknown for 24 (16%) patients. Overall, 92 patients (18%) had no formal education. More than half of the patients (341; 66%) were semi-skilled workers. Most patients lived in rented houses (288; 56%). The median household size was three persons (IQR: 2--4 persons) and 408 (80%) patients earned \< 200 USD per month.Table 1Patient characteristics of new smear-positive adult pulmonary tuberculosis (TB) cases in the Temeke District, Dar es Salaam, TanzaniaVariableAllDelay durationPrior medicationHC facility visits*n* = 513(weeks)*n* (%)≤ 3\> 3Not usedUsed≤ 2 visits\> 2 visitsTotal513 (100)406 (79)107 (21)52 (10)461 (90)297 (58)216 (42)Age, years 18--2491 (18)73 (18)18 (17)6 (12)85 (18)58 (20)33 (15) 25--45333 (65)264 (65)69 (64)37 (71)296 (64)199 (67)134 (59)  \> 4589 (17)69 (17)20 (19)9 (17)80 (17)40 (13)49 (23)Sex Male353 (69)280 (69)73 (68)38 (73)315 (68)209 (70)144 (67) Female160 (31)126 (31)34 (32)14 (27)146 (32)88 (30)72 (33)HIV status Positive146 (28)119 (29)27 (25)16 (31)130 (28)73 (25)73 (34) Negative367 (72)287 (71)80 (75)36 (69)331 (72)224 (75)143 (66)Education No education92 (18)73 (18)19 (18)8 (15)84 (18)46 (15)46 (21) Primary/Secondary404 (79)316 (78)88 (82)44 (85)360 (78)243 (82)161 (75) University17 (3)17 (4)0 (0)0 (0)17 (4)8 (3)9 (4)Occupation Unemployed or h/wife103 (20)86 (21)17 (16)4 (8)99 (21)46 (15)57 (26) Unskilled labour69 (13)52 (13)17 (16)11 (21)58 (13)38 (13)31 (14) Semiskilled labour341 (67)268 (66)73 (68)37 (71)304 (66)213 (72)128 (60)Household income  \< \$200 per month408 (80)329 (81)79 (74)37 (71)371 (80)225 (76)183 (85)  ≥ \$200 per month105 (20)77 (19)28 (26)15 (29)90 (20)72 (24)33 (15)BMI category, kg/m^2^  \< 18.536 (7)29 (7)7 (7)3 (6)33 (7)25 (8)11 (5) 18--24.9273 (53)204 (50)69 (64)20 (38)253 (55)163 (55)110 (51) 25--29.9154 (30)129 (32)25 (23)19 (37)135 (29)78 (26)76 (35)  \> 3050 (210)44 (11)6 (6)10 (19)40 (9)31 (11)19 (9)Household size, persons  ≥ 4137 (27)123 (30)14 (13)3 (6)134 (29)56 (19)81 (37) 2--3331 (64)256 (63)75 (70)43 (83)288 (63)208 (70)123 (57) Single45 (9)27 (7)18 (17)6 (12)39 (8)33 (11)12 (6)House ownership Own225 (44)178 (79)47 (21)17 (33)208 (45)127 (43)98 (45) Rented288 (56)228 (79)60 (21)35 (67)253 (55)170 (57)118 (55)Coughing No2 (0.5)2 (0.5)00 (0)2 (0.4)1 (0.3)1 (0.5) Yes511 (99.5)404 (99.5)107 (100)52 (100)459 (99.6)296 (99.7)215 (99.5)Fever No38 (7)37 (9)1 (1)3 (6)35 (8)33 (11)5 (2) Yes475 (93)369 (91)106 (99)49 (94)426 (92)264 (89)211 (98)Chest pain No102 (20)69 (17)33 (31)40 (77)62 (14)94 (32)8 (4) Yes411 (80)337 (83)74 (69)12 (23)399 (87)203 (68)208 (96)Haemoptysis No336 (71)324 (80)42 (39)52 (100)314 (68)185 (62)181 (84) Yes147 (29)82 (20)65 (61)0147 (32)112 (38)35 (16)Night sweat No26 (5)25 (6)1 (1)1 (2)25 (5)24 (8)2 (1) Yes487 (95)381 (94)106 (99)51 (98)436 (95)273 (92)214 (99)Unexplained weight loss No20 (4)18 (4)2 (2)1 (2)19 (4)15 (5)5 (2) Yes493 (96)388 (96)105 (98)51 (98)442 (96)282 (95)211 (98)*BMI* body mass index, *h/wife* housewife, *TB* tuberculosis, *HC facility* health care facility

The most commonly reported symptom was coughing (511 patients; 99.6%), followed by weight loss (493; 96%), night sweats (487; 94%), fever (475; 93%), chest pain (411; 80%), and hemoptysis (147; 29%) (Table [1](#Tab1){ref-type="table"}). The median duration of cough was 3 weeks (IQR: 3.0--3.0). All other symptoms had a median duration of 2 weeks (IQR: 1.0--3.0).

Health-seeking behaviour and diagnostic delay {#Sec10}
---------------------------------------------

About 444 (87%) patients reported seeking care from at least one of the formal health care providers; of these, 211 (48%) sought care at a HCF three times or more in relation to TB symptoms prior to TB diagnosis. Only six (1%) reported to have sought care from traditional healers and 63 (12%) did not seek care until they presented to the HCFs of the study recruitment centers, where they were diagnosed with TB. The median age of those who sought care three times or more was 35 years (IQR: 29--44). More men than women sought formal care three times or more (67% versus 33%). Almost all patients reported cough (Table [1](#Tab1){ref-type="table"}). The majority of patients reported having taken medication prior to TB diagnosis (461 patients; 90%); amoxicillin was the most common drug of choice (432; 94%), followed by ciprofloxacin (5; 1%).

The median diagnostic delay time was 3 weeks (IQR: 3.0--3.0, range 1--45 weeks); 28 (5%) patients had a diagnostic delay of more than 4 weeks. By the third week of presenting with TB symptoms, 442 (86%) patients had been diagnosed with the disease. Additional file [2](#MOESM2){ref-type="media"}: Figure S1 shows the distribution of the diagnostic delay in the study population.

Patient factors associated with diagnostic delay {#Sec11}
------------------------------------------------

In the multivariate analysis, diagnostic delay of \> 3 weeks was more likely among patients who did not have chest pain (a*OR* = 7.97, 95% *CI*: 3.15--20.19; *P* \< 0.001), and who presented with hemoptysis (a*OR* = 25.37, 95% *CI*: 11.15--57.74; *P* \< 0.001), and less likely among patients who used medication prior to TB diagnosis (a*OR* = 0.31, 95% *CI*: 0.14--0.71; *P* = 0.03) as shown in Table [2](#Tab2){ref-type="table"}. Age, sex, HIV status, occupation, level of income, household size, and visits to HCF were not associated with diagnostic delay (Table [2](#Tab2){ref-type="table"}).Table 2Associations of diagnosis delay (defined as \> 3 weeks) with socio-demographic and clinical characteristics among new pulmonary TB patientsCharacteristicCasesUnadjustedAdjusted*n* (%)*OR* (95% *CI*)*P*-valuea*OR* (95% *CI*)*P*-valueAge, years0.70.7 18--2491 (18)11 25--45333 (65)1.06 (0.59--1.89)0.81 (0.39--1.67)  \> 45189 (17)1.18 (0.57--2.41)1.08 (0.44--2.66)Sex0.90.6 Female160 (31)11 Male353 (69)0.97 (0.61--1.53)0.84 (0.46--1.51)HIV status0.40.5 Negative366 (71)11 Positive147 (29)0.81 (0.50--1.30)0.83 (0.46--1.52)Occupation0.40.1 Unemployed, or h/wife103 (20)11 Unskilled labor69 (13)1.65 (0.78--3.52)1.24 (0.48--3.26) Semiskilled labor341 (67)1.38 (0.77--2.46)0.69 (0.32--1.51)Household income0.10.3  \< \$200 per month408 (80)11  ≥ \$200 per month105 (20)1.51 (0.92--2.49)1.34 (0.73--2.47)Household size, persons\< 0.0010.2  ≥ 4137 (27)11 2--3331 (64)2.57 (1.40--4.74)1.38 (0.67--2.83) Single45 (9)5.86 (2.60--13.21)1.81 (0.71--4.59)Visits to a HCF\< 0.0010.9  \> 2216 (42)11  ≤ 2297 (58)3.31 (2.01--5.46)0.99 (0.52--1.90)Prior purchase of medication0.0010.01 No52 (10)11 Yes461 (90)0.37 (0.20--0.68)0.31 (0.14--0.71)Chest pain0.002\<0.001 Yes411 (80)11 No102 (20)2.18 (1.34--3.54)7.97 (3.15--20.19)Hemoptysis\<0.001\<0.001 No366 (71)11 Yes147 (29)6.11 (3.87--9.66)25.37 (11.15--57.74)*OR* odds ratio, a*OR* adjusted odds ratio, 95% *CI*, 95% confidence interval, *h/wife* housewife, *HCF* health care facilityModel was adjusted for age, sex, HIV status, occupation, house hold income, household size, visit to HCF, prior use of medication, chest pain and hemoptysis

Health-seeking behaviour and geographical distance to pharmacies {#Sec12}
----------------------------------------------------------------

The map in Fig. [2](#Fig2){ref-type="fig"} shows the spatial distribution of pharmacies and HCFs in the study area, and offers examples of the complex pathways to care until final TB diagnosis. We counted a total of 35 pharmacies within the catchment area of the study. The median Euclidean distance from a participant's household to the nearest pharmacy was 412.3 meters (IQR: 254--781, range 6--4 820). More than half of participants' households (303; 59%) were found within 500 meters of their nearest pharmacy; 137 (26.7%) were between 500 and 1 000 meters to the nearest pharmacy and only 73 (14.2%) participants' households were more than 1 000 meters away from a pharmacy. For each incremental increase of 500 meters away from a pharmacy, the odds of visiting a HCF decreased (*OR* = 0.51, 95% *CI*: 0.28--0.96; *P* = 0.037, comparing patients with any visit to a HCF versus no visit prior to TB diagnosis, Fig. [3](#Fig3){ref-type="fig"}). Geographical distance did not seem to have an effect on the use of medication prior to TB diagnosis or on the degree of diagnostic delay.Fig. 2Geographical analyses of health care facilities (HCFs) and pathways to care of patients with tuberculosis (TB) symptoms in the study area, Temeke District, Dar es Salaam, Tanzania. Panel **a**: Localization of the two governmental TB clinics which serve as recruitment sites in the study area (in *red*). Panel **b**: Spatial distribution of pharmacies and HCFs in the study area. Panel **c**: Five examples of possible pathways to care of patients with TB symptoms seeking care. Various types of HCFs as the entry point into the health care system (single or multiple visits) until final diagnosis at the TB clinic are presented Fig. 3Association between health-seeking behaviour and geographical distances to pharmacies. The regression coefficient plot (with corresponding 95% confidence intervals) shows the association of the Euclidean distance between participants' households to the nearest pharmacy with purchase of medication prior to TB diagnosis, diagnostic delay (\> 3 weeks), and visit of any HCF before TB diagnosis. Odds Ratios (*OR*) above 1 indicate that the factor is more likely with increasing distance away from the nearest pharmacy, and an *OR* below 1 that the factor is more likely the closer the household is to a pharmacy. HCF, health care facility

Discussion {#Sec13}
==========

We studied diagnostic delay among adult infectious TB patients in an urban district of Dar es Salaam, Tanzania, with a high TB notification rate. We found that multiple visits to HCFs and prior use of prescribed or self-prescribed medication was frequent (41% and 90%) and that multiple visits were more likely among patients living closer to HCFs.

We showed that 21% of patients delayed seeking care for TB symptoms. The median diagnostic delay of 3 weeks in our study was shorter compared to other delay studies conducted in sub-Saharan Africa, Asia as well as Eastern Europe \[[@CR5], [@CR26]--[@CR30]\]. A systematic review from low- and high-income settings reported a median total delay of 3--26 weeks \[[@CR23]\]. Our diagnostic delay (time from onset of symptoms until diagnosis) was also shorter than the treatment delay (time from onset of symptoms until treatment) reported in a study conducted in six rural and urban districts in Tanzania (median treatment delay time was 10--14.5 weeks) \[[@CR31]\]. In our study, we disregarded the treatment delay because all patients were strictly put on TB treatment within 1 day of confirming TB diagnosis, as per the guidelines of the NTLP.

We found that more than three quarters of patients sought formal care prior to being diagnosed with TB, with nearly half of them seeking care more than twice. This indicates that a high proportion of TB patients is seen by several different health care providers before receiving a TB diagnosis, suggesting a low suspicion index among health care providers. The first national TB prevalence survey in Tanzania reported that one third of patients suspected of having TB sought care before the survey, which confirms that many infectious TB cases are missed by the health care system in Tanzania \[[@CR4]\]. Furthermore, a study from Uganda showed that the proportion of patients who sought care before being diagnosed with TB can be as high as 80% \[[@CR32]\].

We also found that use of medication prior to TB diagnosis was associated with shorter diagnostic delays. This could be explained by the fact that patients who did not use medication prior to TB diagnosis could not afford any health care service, feared the stigma of being known to be sick, or did not have adequate knowledge about signs and symptoms of TB. Indeed, inadequate knowledge about TB and stigma has previously been associated with longer diagnostic delays \[[@CR3], [@CR23], [@CR33]--[@CR35]\]. In contrast, studies from Georgia, Ethiopia and Angola reported that the use of antibiotics prior to TB diagnosis was associated with a prolonged delay \[[@CR5], [@CR36], [@CR37]\]. This difference can be explained by the fact that we defined use of medication as any medication prior to TB diagnosis, rather than antibiotics alone, as patients may not accurately remember the type of medication used in the past. Furthermore, patients may tend to wait for improvement of symptoms before seeking health care in these specific study settings and countries, but not in our setting of Dar es Salaam.

Patient factors associated with diagnostic delay may vary considerably across settings and countries \[[@CR8], [@CR28], [@CR29], [@CR33], [@CR38]--[@CR40]\]. In our study, diagnostic delay was not reduced among HIV-positive patients despite the widely implemented TB/HIV collaborative activities by the National AIDS Control Programme and the NTLP in Tanzania \[[@CR17]\]. We also found that chest pain was associated with a shorter diagnostic delay, in contrast to studies from Afghanistan and Brazil \[[@CR41], [@CR42]\]. Hemoptysis, which usually presents at the later stage of disease \[[@CR43]\], was associated with a prolonged delay in our study. Patients presenting with hemoptysis may tend to ignore other TB symptoms until the disease is advanced and hemoptysis has developed. Systematic reviews reported the opposite trend, possibly because hemoptysis may necessitate health care providers to investigate for TB early on \[[@CR8], [@CR44]\]. Consistent with our results, previous studies found no association of diagnostic delay with patients' sex \[[@CR33]\] or low-income class \[[@CR8]\].

We also investigated the impact of the geographical distance on the health-seeking behaviour of patients with TB symptoms using geographic information system (GIS) tools. GIS is increasingly being used to describe the epidemiology of diseases and to map HCFs for strategic planning of public health measures \[[@CR45]--[@CR47]\]. We found that patients living closer to a pharmacy tended to visit facilities more frequently. This suggests that the availability of health care services (public/private) affects use by the resident population. In line with our results, a study from Tanzania showed that residing at a distance of more than 5 km from a TB diagnostic center was associated with diagnostic delay \[[@CR29]\]. In addition, a systematic review found that a longer walking distance to a HCF was correlated with patient delay, defined as the time from onset of the first TB symptoms (usually described as the onset of persistent coughing) until the date of the first HCF consultation \[[@CR44]\].

Our study has several limitations. First, we had to rely on patients' recall of previous interactions with the health care system. This could have introduced a recall bias influencing the accuracy of the data. However, our interviewers were well trained in patient interviews and experienced in conducting scientific studies. Therefore, the collected information was likely to be accurate. Second, our findings may be specific to urban settings in Tanzania such as Dar es Salaam as well as to the study period and, therefore, may not be generalizable. Finally, we did not collect detailed information on the pathway to care at the individual level, such as dates and types of HCF visited, patients' reasons for delay or socio-cultural factors underlying the delay in seeking care.

Conclusions {#Sec14}
===========

In conclusion, we found that TB diagnostic delay was common in urban Tanzania, possibly due to passive case detection practice. We also found that the use of medication prior to TB diagnosis was common, which potentially poses challenges in the rational use of medication. Since many patients repeatedly accessed health care services before being diagnosed with TB, our study re-emphasizes the need for improved diagnostic capacities, as well as training and re-training of health care workers to increase awareness and timely diagnosis of TB. Consequent systematic screening for TB at HCFs at any care level could further reduce the diagnostic delay to interrupt TB transmission in the community. To support the implementation of active case detection interventions, future research should focus on health-seeking behaviour and how it is affected by cost factors and by the role of socio-cultural and other community determinants \[[@CR12], [@CR48]--[@CR50]\].
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